NeuroSense Therapeutics Ownership & Insider Activity

NeuroSense Therapeutics (NRSN) institutional and insider ownership, recent insider transactions and ownership breakdown.

Net Insider Activity by Month

NeuroSense Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Jun 16, 2026	Or Eisenberg	CHIEF FINANCIAL OFFICER	BUY	250.000K	$0.80	$200K
Jun 16, 2026	Alon Ben-Noon	CHIEF EXECUTIVE OFFICER	BUY	250.000K	$0.80	$200K